Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,169 | 230 | 48.7% |
| Travel and Lodging | $4,064 | 16 | 27.6% |
| Consulting Fee | $2,750 | 2 | 18.7% |
| Honoraria | $750.00 | 1 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intersect ENT, Inc. | $3,281 | 24 | $0 (2022) |
| Stryker Corporation | $2,643 | 50 | $0 (2024) |
| AcelRx Pharmaceuticals, Inc. | $2,264 | 2 | $0 (2022) |
| Entellus Medical, Inc. | $1,540 | 14 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $1,417 | 36 | $0 (2024) |
| AERIN MEDICAL INC. | $916.97 | 8 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $509.66 | 22 | $0 (2024) |
| Optinose US, Inc. | $456.21 | 21 | $0 (2024) |
| GENZYME CORPORATION | $411.83 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $326.57 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,311 | 44 | Stryker Corporation ($1,460) |
| 2023 | $864.71 | 31 | GENZYME CORPORATION ($248.84) |
| 2022 | $2,781 | 27 | AcelRx Pharmaceuticals, Inc. ($2,264) |
| 2021 | $1,587 | 39 | AERIN MEDICAL INC. ($757.67) |
| 2020 | $636.93 | 23 | Jazz Pharmaceuticals Inc. ($157.13) |
| 2019 | $2,904 | 31 | Intersect ENT, Inc. ($2,359) |
| 2018 | $1,551 | 29 | Jazz Pharmaceuticals Inc. ($741.33) |
| 2017 | $2,096 | 25 | Entellus Medical, Inc. ($1,527) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $9.23 | General |
| Category: Narcoplepsy | ||||||
| 12/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.42 | General |
| Category: Narcoplepsy | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $27.87 | General |
| Category: Narcoplepsy | ||||||
| 11/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $2.46 | General |
| Category: Narcoplepsy | ||||||
| 11/01/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Narcoplepsy | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.69 | General |
| Category: Narcoplepsy | ||||||
| 09/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: Immunology | ||||||
| 08/06/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $28.59 | General |
| Category: Narcoplepsy | ||||||
| 07/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Narcoplepsy | ||||||
| 06/18/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: Narcoplepsy | ||||||
| 06/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | Stryker Corporation | SCOPIS ENT (Device) | Travel and Lodging | Cash or cash equivalent | $535.50 | General |
| Category: INSTRUMENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,021 | 1,162 | $216,218 | $82,818 |
| 2022 | 15 | 1,055 | 1,217 | $184,450 | $84,740 |
| 2021 | 15 | 1,058 | 1,206 | $194,454 | $90,825 |
| 2020 | 12 | 782 | 904 | $156,188 | $73,375 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 131 | 131 | $39,125 | $16,000 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 144 | $31,900 | $13,521 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 200 | $34,600 | $13,069 | 37.8% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 93 | 104 | $20,800 | $10,574 | 50.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 100 | 100 | $19,940 | $7,841 | 39.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 34 | $11,900 | $4,781 | 40.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 114 | 120 | $12,000 | $3,874 | 32.3% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 21 | 23 | $6,900 | $3,489 | 50.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 50 | 52 | $20,800 | $3,456 | 16.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 65 | $7,885 | $2,685 | 34.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,200 | $1,557 | 37.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $2,825 | $1,049 | 37.1% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 22 | 24 | $1,920 | $607.48 | 31.6% |
| 92567 | Test to assess middle ear function | Office | 2023 | 19 | 21 | $735.00 | $220.32 | 30.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 54 | 110 | $687.50 | $93.09 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 113 | 113 | $31,075 | $14,360 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 202 | $25,350 | $14,184 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 126 | $22,050 | $12,697 | 57.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 94 | 106 | $21,200 | $10,768 | 50.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 109 | 109 | $20,165 | $8,655 | 42.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 129 | 144 | $14,400 | $5,183 | 36.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 98 | $8,330 | $4,463 | 53.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 31 | 34 | $9,520 | $3,819 | 40.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 22 | 22 | $6,600 | $3,456 | 52.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 34 | 34 | $13,600 | $2,590 | 19.0% |
About Dr. Arthur Rosner, MD
Dr. Arthur Rosner, MD is a Sleep Medicine healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790781573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Rosner, MD has received a total of $14,732 in payments from pharmaceutical and medical device companies, with $2,311 received in 2024. These payments were reported across 249 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($7,169).
As a Medicare-enrolled provider, Rosner has provided services to 3,916 Medicare beneficiaries, totaling 4,489 services with total Medicare billing of $331,759. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Sleep Medicine
- Other Specialties Otolaryngology
- Location Rochester Hills, MI
- Active Since 06/25/2005
- Last Updated 10/29/2020
- Taxonomy Code 207YS0012X
- Entity Type Individual
- NPI Number 1790781573
Products in Payments
- PROPEL (Device) $2,520
- DSUVIA (Drug) $2,264
- SCOPIS ENT (Device) $1,424
- XprESS Multi-Sinus Dilation System (Device) $833.37
- Xyrem (Drug) $797.26
- VIVAER STYLUS (Device) $772.49
- SINUVA (Drug) $760.52
- DUPIXENT (Biological) $751.53
- XprESS Sinus and Eustachian Tube Dilation Tool (Device) $693.19
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $574.18
- Xhance (Drug) $456.21
- XYWAV (Drug) $320.37
- Wakix (Drug) $276.25
- WAKIX (Drug) $233.41
- NUCALA (Biological) $227.30
- SUNOSI (Drug) $227.27
- Sunosi (Drug) $186.18
- ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE (Device) $152.35
- Vivaer RF Stylus (Device) $144.48
- XPRESS ENT DILATION SYSTEM (Device) $126.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.